Humacyte: Benchmark maintains Buy, PT down to $11 from $14.

Thursday, Nov 13, 2025 1:46 pm ET1min read
HUMA--

Humacyte: Benchmark maintains Buy, PT down to $11 from $14.

Humacyte: Benchmark maintains Buy, PT down to $11 from $14.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet